Mengling Feng1, Jakob I McSparron2, Dang Trung Kien1, David J Stone3, David H Roberts4, Richard M Schwartzstein4, Antoine Vieillard-Baron5, Leo Anthony Celi4,6. 1. Saw Swee Hock School of Public Health, National University Health System, National University of Singapore, Singapore, Singapore. 2. Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, USA. jmcsparr@med.umich.edu. 3. Departments of Anesthesiology and Neurosurgery, University of Virginia School of Medicine, Charlottesville, USA. 4. Division of Pulmonary, Critical Care and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, USA. 5. Hospital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Boulogne, France. 6. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, USA.
Abstract
PURPOSE: While the use of transthoracic echocardiography (TTE) in the ICU is rapidly expanding, the contribution of TTE to altering patient outcomes among ICU patients with sepsis has not been examined. This study was designed to examine the association of TTE with 28-day mortality specifically in that population. METHODS AND RESULTS: The MIMIC-III database was employed to identify patients with sepsis who had and had not received TTE. The statistical approaches utilized included multivariate regression, propensity score analysis, doubly robust estimation, the gradient boosted model, and an inverse probability-weighting model to ensure the robustness of our findings. Significant benefit in terms of 28-day mortality was observed among the TTE patients compared to the control (no TTE) group (odds ratio = 0.78, 95% CI 0.68-0.90, p < 0.001). The amount of fluid administered (2.5 vs. 2.1 L on day 1, p < 0.001), use of dobutamine (2% vs. 1%, p = 0.007), and the maximum dose of norepinephrine (1.4 vs. 1 mg/min, p = 0.001) were significantly higher for the TTE patients. Importantly, the TTE patients were weaned off vasopressors more quickly than those in the no TTE group (vasopressor-free days on day 28 of 21 vs. 19, p = 0.004). CONCLUSION: In a general population of critically ill patients with sepsis, use of TTE is associated with an improvement in 28-day mortality.
PURPOSE: While the use of transthoracic echocardiography (TTE) in the ICU is rapidly expanding, the contribution of TTE to altering patient outcomes among ICU patients with sepsis has not been examined. This study was designed to examine the association of TTE with 28-day mortality specifically in that population. METHODS AND RESULTS: The MIMIC-III database was employed to identify patients with sepsis who had and had not received TTE. The statistical approaches utilized included multivariate regression, propensity score analysis, doubly robust estimation, the gradient boosted model, and an inverse probability-weighting model to ensure the robustness of our findings. Significant benefit in terms of 28-day mortality was observed among the TTE patients compared to the control (no TTE) group (odds ratio = 0.78, 95% CI 0.68-0.90, p < 0.001). The amount of fluid administered (2.5 vs. 2.1 L on day 1, p < 0.001), use of dobutamine (2% vs. 1%, p = 0.007), and the maximum dose of norepinephrine (1.4 vs. 1 mg/min, p = 0.001) were significantly higher for the TTE patients. Importantly, the TTE patients were weaned off vasopressors more quickly than those in the no TTE group (vasopressor-free days on day 28 of 21 vs. 19, p = 0.004). CONCLUSION: In a general population of critically illpatients with sepsis, use of TTE is associated with an improvement in 28-day mortality.
Entities:
Keywords:
Critical care; Echocardiography; Sepsis; Value
Authors: James Dean Sandham; Russell Douglas Hull; Rollin Frederick Brant; Linda Knox; Graham Frederick Pineo; Christopher J Doig; Denny P Laporta; Sidney Viner; Louise Passerini; Hugh Devitt; Ann Kirby; Michael Jacka Journal: N Engl J Med Date: 2003-01-02 Impact factor: 91.245
Authors: Eduardo Bossone; Bruno DiGiovine; Sara Watts; Pamela A Marcovitz; Louise Carey; Charles Watts; William F Armstrong Journal: Chest Date: 2002-10 Impact factor: 9.410
Authors: D Tony Yu; Richard Platt; Paul N Lanken; Edgar Black; Kenneth E Sands; J Sanford Schwartz; Patricia L Hibberd; Paul S Graman; Katherine L Kahn; David R Snydman; Jeffrey Parsonnet; Richard Moore; David W Bates Journal: Crit Care Med Date: 2003-12 Impact factor: 7.598
Authors: Tobias M Merz; Luca Cioccari; Pascal M Frey; Andreas Bloch; David Berger; Bjoern Zante; Stephan M Jakob; Jukka Takala Journal: Intensive Care Med Date: 2019-07-04 Impact factor: 17.440
Authors: R F Trauzeddel; M Nordine; H V Groesdonk; G Michels; R Pfister; D A Reuter; T W L Scheeren; C Berger; S Treskatsch Journal: Anaesthesist Date: 2021-03-03 Impact factor: 1.041
Authors: R F Trauzeddel; M Ertmer; M Nordine; H V Groesdonk; G Michels; R Pfister; D Reuter; T W L Scheeren; C Berger; S Treskatsch Journal: J Clin Monit Comput Date: 2020-05-26 Impact factor: 2.502
Authors: Daniele Bottigliengo; Giulia Lorenzoni; Honoria Ocagli; Matteo Martinato; Paola Berchialla; Dario Gregori Journal: Int J Environ Res Public Health Date: 2021-06-22 Impact factor: 3.390
Authors: Fangyu Chen; Jordan M Komisarow; Brianna Mills; Monica Vavilala; Adrian Hernandez; Daniel T Laskowitz; Joseph P Mathew; Michael L James; Krista L Haines; Karthik Raghunathan; Matt Fuller; Raquel R Bartz; Vijay Krishnamoorthy Journal: Anesth Analg Date: 2021-04-01 Impact factor: 6.627